Cormorant Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $11.9M | Hold |
|
|||||
|
2017
Q2 | $15.8M | Hold |
|
|||||
|
2017
Q1 | $16.6M | Sell |
|
|||||
|
2016
Q4 | $32.5M | Sell |
|
|||||
|
2016
Q3 | $31.9M | Sell |
|
|||||
|
2016
Q2 | $19.6M | Buy |
|
|||||
|
2016
Q1 | $20.3M | Buy |
|
|||||
|
2015
Q4 | $35.5M | Buy |
|
|||||
|
2015
Q3 | $22.2M | Hold |
|
|||||
|
2015
Q2 | $24.3M | Sell |
|
|||||
|
2015
Q1 | $30M | Buy |
|
|||||
|
2014
Q4 | $6.2M | Hold |
|
|||||
|
2014
Q3 | $5.06M | Hold |
|
|||||
|
2014
Q2 | $5.73M | Hold |
|
|||||
|
2014
Q1 | $5.1M | Buy |
|